1. Introduction {#s0005}
===============

Polycystic ovary syndrome (PCOS) is a most common endocrine disorder prevailing in reproductive age women across the world. It is identified with chronic anovulation and hyperandrogenism [@bb0005]. The symptoms associated with PCOS are obesity and several dermatological features. PCOS are found to have a significant reproductive and metabolic impact, which may result in type-2-diabetes or cardiovascular disease [@bb0010]. A mutation in PCOS proteins interacts with multiple inherited and environmental factors. Multiple inherited genes are responsible for the occurrence of PCOS. In India, the prevalence of PCOS was 22.5% by Rotterdam and 10.7% by Androgen Excess Society criteria. Mild PCOS is one of the most common phenotype occurring in about 52.6% of women [@bb0015]. The following study deals with in-depth genetic and phylogenetic analyses of all the genes related to PCOS. Microarray analyses were performed using 'R' to identify the highly expressed genes among all the selected ones for the study.

2. Genetics of PCOS {#s0010}
===================

2.1. Ovary and adrenal steroidogenesis {#s0015}
--------------------------------------

### 2.1.1. CYP11A {#s0020}

The conversion of cholesterol into progesterone is the first step of steroidogenesis. It is catalyzed by P450. A gene known as CYP11A that is located at 15q24 encodes P450. CYP11A gene also shows the association in the serum testosterone levels. The CYP11A alleles also show the association with 5′ untranslated region (5′ UTR) [@bb0020].

### 2.1.2. CYP17A1 {#s0025}

CYP17A1 converts pregnenolone and progesterone into 17-hydroxypregnenolone and 17-hydroxyprogesterone and invert these steroids into didehydroepiandrosterone (DHEA) and Δ4-Androstendione (Δ4Α), which is catalyzed by the P450c17 enzyme. The P450c17 enzyme has activities such as 17,20-lyase and 17-hydroxylase activities. P450c17 is encoded by CYP17A, which is located at 10q27.3. It was proclaimed that the P450c17 enzyme activity and expression increases in ovary theca cells from women with PCOS [@bb0020].

### 2.1.3. CYP19 {#s0030}

CYP19 converts androgen to estrogen. The enzyme complex is composed of cytochrome P450 aromatase and NADPH cytochrome P450 reductase, and P450arom is encoded by CYP19 located at 15p21.1. Aromatase deficiency has been reported in a number of people having hyperandrogenism. With comparison to the control follicles all the PCOS follicles have estradiol, bioactivity of lower aromatase stimulation [@bb0020]. This shows that the aromatase activity might be decreased in PCOS follicles and the excess androgen leads to the improper follicle development.

### 2.1.4. HSD17B1 & HSD17B2 {#s0035}

They belong to the group of alcohol oxidoreductase, which catalyze the dehydrogenation of 17-hydroxysteroids in steroidogenesis. They include the interconversion of androstenedione and testosterone, DHEA and androstenediol and estrone and estradiol. A higher level of expression of mRNA synthesizing and inactivating enzyme in women has been reported without PCOS endometrial treatment [@bb0025].

### 2.1.5. HSD3B1 & HSD3B2 {#s0040}

The type I 3β-HSD isoenzyme is expressed in placenta and peripheral tissues, whereas the type II 3β-HSD isoenzyme is expressed in the adrenal gland, ovary, and testis. (HSD3B) deficiency in hyperandrogenic females (HF) is related to insulin-resistant polycystic ovary syndrome (PCOS) [@bb0025].

### 2.1.6. StAR {#s0045}

The Steroidogenic Acute Regulatory protein is also known as StAR. StAR is a kind of a transport protein, which transports cholesterol within the mitochondria [@bb0030]. In some patients, PCOS is caused maybe due to the defect of steroidogenesis, which results in the increased level of the ovary and adrenal androgen productions. The steroidogenesis process is initiated by the action of steroidogenic acute regulatory protein (StAR) [@bb0030].

2.2. Steroid hormone actions {#s0050}
----------------------------

### 2.2.1. Androgen receptor {#s0055}

Hypersecretion of androgen is one of the most common characteristics in PCOS. This situation results in an excess of androgen production by the ovary. It is known as Hyper-Androgenism, which is the second important characteristic leading to PCOS. 17% to 83% of women are in prevalence to this disorder [@bb0035].

### 2.2.2. SHBG {#s0060}

Patients with hyperandrogenism and PCOS have a low level of Serum Sex Hormone-Binding Globulin (SHBG). PCOS results in Hyperinsulinemia, which causes a decrease in the levels of SHBG. The synthesis of SHBG in the liver is suppressed [@bb0045].

2.3. Gonadotropin action and regulation {#s0065}
---------------------------------------

### 2.3.1. LH, FSH {#s0070}

Inappropriate gonadotropin secretion is an important characteristic of PCOS. An elevated level of LH is one of the common reasons of PCOS. Females affected with PCOS have high LH secretion and low FSH secretion. The ratio used to indicate abnormal gonadotropin secretion is normally 2--3/1 [@bb0040]. PCOS is usually characterized by low levels of follicle stimulating hormone (FSH). It is responsible for stimulating the growth of follicles in the ovaries. They contain maturing eggs. If FSH were absent for a longer period of time then the follicle would not mature and would not release eggs. Thus, this would result in infertility. The immature follicles in ovaries will lead to the production of small cysts [@bb0050].

### 2.3.2. Inhibin βA and Inhibin βB {#s0075}

PCOS is a syndrome associated with insulin resistance. Inhibin is a heterodimer responsible for the regulation of FSH secretion [@bb0055]. The increase in FSH concentrations can be suppressed by the release of inhibin. It has got two variants Inhibin A and Inhibin B. Gonads, pituitary gland, placenta etc. secrete it. Inhibin B is more important than Inhibin A during the follicular phase. Woman with PCOS possesses high inhibin level than the normal ones [@bb0050].

### 2.3.3. MADH4 {#s0080}

Mothers against decapentaplegic homolog 4 are a protein involved in signaling in mammals. The protein belongs to SAMD family. SAMD4 has two functional domains MH1 and MH2 consist of a tridimensional structure (Regions M and H represent MAD homology). This resembles similarity between SAMD4 in mammals and Drosophila protein.

2.4. Insulin action and secretion {#s0085}
---------------------------------

### 2.4.1. Insulin and IGF-I {#s0090}

Insulin and IGF-I are responsible for simulating ovary growth. They increase the action of gonadotropins on ovary steroid synthesis. Insulin is responsible for augmenting the concentration of IGF-I and androgens. It does this by regulating the synthesis of IGFBP-1 and SHBG in the liver. Resistance to insulin is one of the common symptoms of PCOS. Increase in insulin level and IGFBP-1 activity can be considered as the important reasons resulting in PCOS [@bb0060].

### 2.4.2. Insulin VNTR gene, IGF-II, insulin receptor gene and insulin receptor substrate {#s0095}

The insulin gene consists of variable number tandem repeat (VNTR) present at the 5′ regulatory region. Polymorphism of VNTR is responsible for regulation of the transcriptional rate of insulin. It also regulates the gene encoding IGF-II. The Class-I alleles are made up of a length of 40 repeats and Class-II alleles are composed of 80 repeats. PCOS results in insulin resistance and may directly have an effect on pancreatic β-cell. VNTR polymorphism has a wide effect on the insulin resistance in some PCOS phenotypes. SNP at tyrosine kinase domain of INSR is found to be associated with PCOS [@bb0050].

### 2.4.3. PPAR-γ {#s0100}

PPARγ is also known as Peroxisome proliferator-activated receptor gamma. It is an important nuclear transcription factor. It is involved in regulation of glucose, lipid metabolism, and ovary steroidogenesis. The most extensive findings on polymorphism in PPARγ encompass Proline and Alanine in exon B. One more polymorphism studied in PPARγ gene is C1431T in exon6. This variation is associated with PCOS. PPARγ gene has an influence on insulin resistance path physiology in women affected with PCOS [@bb0065].

2.5. Obesity and energy regulation {#s0105}
----------------------------------

### 2.5.1. Leptin and leptin receptor {#s0110}

Leptin plays an essential role in the pathological process of PCOS. Obese PCOS affected females the leptin and the free leptin index are higher than thin PCOS subjects. PCOS results in elevation of free leptin index and decrease in leptin receptor. Leptin and leptin receptors are associated with PCOS, which are dependent on BMI [@bb0070], [@bb0075].

### 2.5.2. POMC {#s0115}

POMC is also known as Pro-opiomelanocortin fragments. They are used for identification of factors resulting in excessive adrenal androgen secretion. POMC is a 16K fragment [@bb0080].

### 2.5.3. UCP2 + 3 {#s0120}

UCP2 stands for uncoupling protein, which is responsible for androgen synthesis of granulose cells from PCOS, affected patients. The increase in expression of ovary UCP2 was identified when treated with T3 (triiodothyronine) in PCOS. This may alter pregnenolone synthesis resulting in influencing P450scc expression. This thus affects testosterone production [@bb0085], [@bb0090].

3. Collection of genes related to PCOS {#s0125}
======================================

[Table 1](#t0005){ref-type="table"} consists of 43 genes that are related to the polycystic ovary syndrome (PCOS) also known as Hyperandrogenic Ovulation (HA). PCOS is a disorder that affects women due to the chronic ovulation & hyperandrogenism; PCOS is also a major cause of infertility that is observed in women [@bb0090]. Chromosomal location is retrieved from the Ensembl database [@bb0095]. The UniprotKB ID is taken from UniprotKB [@bb0100]. The retrieval of protein sequences & the accession number is done from National Center for Biotechnology Information (NCBI) [@bb0105].

4. Phylogenetic analysis {#s0130}
========================

All the 43 protein sequences of genes related to PCOS were aligned using Clustal Omega and an unrooted tree is generated as shown in ([Fig. 1.1](#f0005){ref-type="fig"}) [@bb0110]. Phylogenetic analysis was done from the cladogram generated by the alignment ([Fig. 1.2](#f0010){ref-type="fig"}). Visualizing the cladogram using tree viewer identified closely related genes. A cladogram is used to show relatedness between all the responsible genes for PCOS. A clade is a group of species used in cladogram to represent genes having the same ancestral origin. The closely related proteins identified were CYP11A-cytochrome P450 side-chain cleavage enzyme (P05108), Sex hormone binding globulin (ABY68008), Mothers against decapentaplegic homolog 4 (NP_005350), Mothers against decapentaplegic homolog 4 (Q13485.1), Activin receptor 2A Marker Locus (P27037), and Activin receptor 2B Marker (Q13705), Mothers against decapentaplegic homolog 4 (NP_005350), and Mothers against decapentaplegic homolog 4 (Q13485.1) are found to be equidistant from a root node and hence can be considered as related to each other. Similarly for P27037, Q13705, P05108, ABY68008. The relatedness between all the identified genes can be further studied using string analysis.

5. String analysis {#s0135}
==================

The closely related genes that we identified from Clustal Omega were analyzed using string analysis server and the string network was obtained ([Fig. 2](#f0015){ref-type="fig"}) [@bb0115]. In the above string network analysis, all the nodes like ACV2A represent Activin A receptor, type IIA, ACVR2B represents Activin A receptor, type IIB, CYP11A1 represents cytochrome P450, family 11, subfamily A, polypeptide 1, SMAD4 represents SMAD family member 4. This network forms a triangular interaction between SMAD4, ACVR2A and ACVR2B within the nodes of the different colors of interaction lines representing a different form of evidence such as the yellow line represents text-mining evidence, the red line indicates the presence of fusion evidence, light blue line represents database evidence. CYP11A1 is a protein, which does not have any interaction with the other proteins.

6. Tertiary structures {#s0140}
======================

All the 43 genes listed in ([Table 1](#t0005){ref-type="table"}) were searched for existing 3D structures in protein data bank [@bb0120] and listed with their PDB ID in tabular format. Out of the 43 genes, 15 genes had no significant structures present in PDB and hence they were modeled using different modeling techniques. Based on the BLASTp [@bb0125] score obtained for individual genes the way of modeling the 3D structure was done using Modeller and Ab-initio programs. Sequences having low identity and query coverage were modeled using Raptor X [@bb0130], a server for ab-intio modeling of protein tertiary structures. While those sequences having good blast score were modeled using Modeller v9.14 [@bb0135]. ([Table 2](#t0010){ref-type="table"}) consists of genes with their modeled structures along with the tool used for modeling.

7. Microarray analysis of PCOS genes {#s0145}
====================================

7.1. Gene datasets {#s0150}
------------------

The Gene Expression Omnibus (GEO) [@bb0155] is a database consists of microarray, next generation sequencing and other forms of high-throughput genomic data that archives and freely available for scientific research purposes. PCOS gene dataset was obtained from GEO viz. GSE34526 (polycystic ovary syndrome: granulosa cells) [@bb0140] sample count is equal to 10 as shown in ([Fig. 3](#f0020){ref-type="fig"}). The platform of this dataset is GPL570: \[HG-U133_Plus_2\] Affymetrix Human Genome U133 Plus 2.0 Array. This database stores curated gene expression datasets, as well as original series and platform records in the Gene Expression Omnibus (GEO) repository. Dataset records contain additional resources including cluster tools and differential expression queries.

7.2. Analyzing the datasets {#s0155}
---------------------------

R is a freely available software environment, which runs on wide variety of UNIX platforms, Windows and MacOS [@bb0145]. It is used to perform statistical computing and graphical techniques. The various techniques that can be performed using R are linear and nonlinear modeling, classical statistical tests, time-series analysis, classification, clustering, and others.

Bioconductor is free open source software, which is widely used in order to analyze genomic data, generated from wet lab experiments in molecular biology. It is based on statistical R programming. Multi Experiment Viewer (MeV) [@bb0150] is an application, which is used to view processed microarray slide representations. It also identifies genes and expression pattern of interest. The validation of genes obtained from SAM and *t*-test are back validated using this crude analysis. Up-regulated and down-regulated genes were selected from the data obtained from the tests performed.

7.3. Box plot analysis {#s0160}
----------------------

Box plot analysis is a widely used method that provides information about the spread and skewness in the dataset. It is used for visualizing distribution of data values throughout the dataset. [Fig. 3.1](#f0025){ref-type="fig"} and [Fig. 3.2](#f0030){ref-type="fig"} represent the box plot analysis of the gene dataset GSE34526 as before and after normalization.

7.4. Histogram analysis {#s0165}
-----------------------

A histogram is a way of representing a statistical graph having vertical rectangles of different heights, which are proportionate to the corresponding frequencies. It is a graph used for the frequency distribution. [Fig. 3.3](#f0035){ref-type="fig"} represents the histogram curves of the dataset. The microarray data shows histogram as frequency on the y-axis and log transform of pixel intensities along the x-axis.

7.5. SAM results & *t*-test analysis {#s0170}
------------------------------------

The SAM test analysis ([Fig. 3.5](#f0045){ref-type="fig"}) and *t*-test analysis ([Fig. 3.6](#f0050){ref-type="fig"}) of the properly normalized datasets indicated that there are some up-regulated as well as down-regulated genes in the datasets. A list of up-regulated and down-regulated genes, which were common in all the datasets were represented in a tabular format ([Table 3](#t0015){ref-type="table"}). The volcano plot was generated using the normalized data to differentiate the significant with non-significant genes as shown in [Fig. 3.4](#f0040){ref-type="fig"}.

8. Conclusions {#s0175}
==============

Although the genetics and mechanism of PCOS are not yet understood, computational tools may be helpful in finding the cause of this syndrome using various structural aspects. Here in our work, the proteins responsible as reported earlier were subjected to computational modeling using various bioinformatics tools e.g. Modeller. The proteins whose structural homologous were not significant, were subjected to Ab-initio modeling. 43 protein-coding genes were analyzed in structural viewpoint, which could assist computational biologists to carry out further aspects of research. The relatedness of the 43 protein-coding genes was analyzed using Clustal Omega, a phylogeny tool to find out the closely related proteins responsible for PCOS. The work was not restricted to the above said aspects, but statistical analysis of PCOS dataset retrieved from GEO datasets from NCBI (10 samples 3 control and 7 diseased states) were taken into consideration to have an in-sight into the genes that are responsible for PCOS apart from 43 reported proteins. Sam test and *t*-test differentiate the significant from the non-significant genes from the dataset. 14 significant genes were identified and were retrieved from NCBI and Uniprot. Out of the 14 genes, 8 genes were up-regulated genes and the rest 6 genes were reported as down-regulated genes as seen in [Table 3](#t0015){ref-type="table"}. Thus, in conclusion, the computational study of genetic disorders like PCOS can be scrutinized in both sequential and structural aspects to cognize the mechanism of such type of genetic syndromes.
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###### 

List of 43 Genes involved in PCOS with UNIPROT-ID, PDB-ID and chromosomal locations.

Table 1

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Gene name                                                                   Locus                                             Organism         Uniprot ID   Accession number   PDB-ID
  --------------------------------------------------------------------------- ------------------------------------------------- ---------------- ------------ ------------------ --------
  CYP11A-cytochrome P450 side-chain cleavage enzyme (Marker Locus: D15S520)   Chromosome 15: 74,367,990-74,368,179              *Homo Sapiens*   P05108       P05108             3N9Y

  Sex hormone binding globulin                                                Chromosome 17: 7,613,946-7,633,383                *Homo Sapiens*   P04278       ABY68008           1D2S

  Luteinizing hormone choriogonadotropin receptor                             Chromosome 2: 48,708,770-48,723,514               *Homo Sapiens*   P22888.4     P22888             1LUT

  Follicle-stimulating hormone receptor                                       Chromosome 2: 48,962,157-49,154,537               *Homo Sapiens*   P23945       AAB26480           1XUN

  Mothers against decapentaplegic homolog 4                                   Chromosome 18: 51,028,394-51,085,045              *Homo Sapiens*   Q13485       NP_005350          1DD1

  Leptin                                                                      Chromosome 7: 128,241,284-128,257,628             *Homo Sapiens*   P41159       AAH69452           1AX8

  Leptin receptor                                                             Chromosome 1: 65,420,652-65,641,559               *Homo Sapiens*   P48357       AAB09673           3V6O

  Inhibin beta-B                                                              Chromosome 2: 120,346,143-120,351,808             *Homo Sapiens*   P09529       AAH30029           --

  Inhibin beta-A                                                              Chromosome 7: 41,685,114-41,703,108               *Homo Sapiens*   P08476       AAH07858           1NYS

  Inhibin A (gene symbol: INHA)                                               Chromosome 2: 219,569,162-219,575,713             *Homo Sapiens*   P05111       P05111             --

  Pro-opiomelanocortin\                                                       Chromosome 2: 25,160,853-25,168,903               *Homo Sapiens*   P01189       P01189             --
  (gene symbol: POMC)                                                                                                                                                            

  Uncoupling protein 213\                                                     Chromosome 11: 73,974,667-73,983,307              *Homo Sapiens*   P55851       P55851             --
  (gene symbol: UCP2 + 3)                                                                                                                                                        

  Melanocortin 4 receptor                                                     Chromosome 18: 60,371,110-60,372,775              *Homo Sapiens*   P32245       AAO92061           2IQP

  Insulin-like growth factor I                                                Chromosome 12: 102,395,867-102,480,645            *Homo Sapiens*   P05019       CAA40342           1B9G

  Insulin-like growth factor I receptor                                       Chromosome 15: 98,648,971-98,964,530              *Homo Sapiens*   P08069       P08069             1IGR

  Insulin-like growth factor binding protein1 + 3 (gene symbol: IGFBP1 + 3)   Chromosome 7: 45,888,357-45,893,668               *Homo Sapiens*   P08833       P08833             1ZT3

  Insulin gene VNTR (gene symbol: INS VNTR)                                   Chromosome 11: 2,159,779-2,161,341                *Homo Sapiens*   P01308       P01308             1A7F

  Insulin receptor\                                                           Chromosome 19: 7,112,255-7,294,034                *Homo Sapiens*   P06213       AAA59452           1GAG
  (Marker Locus: INSR)                                                                                                                                                           

  Insulin receptor\                                                           Chromosome 19: 4,903,080-4,962,154                *Homo Sapiens*   Q96T88       Q96T88             2FAZ
  (Marker Locus: D19S216)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 7,595,902-7,618,304                *Homo Sapiens*   Q9P1Y5.2     Q9P1Y5             --
  (Marker Locus: D19S905)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 8,065,402-8,149,846                *Homo Sapiens*   Q75N90       Q75N90             --
  (Marker Locus: D19S884)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 8,520,790-8,577,577                *Homo Sapiens*   O00160       O00160             --
  (Marker Locus: D19S391)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 8,580,242-8,610,735                *Homo Sapiens*   Q9H324.2     Q9H324             --
  (Marker Locus: D19S906)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 13,906,201-13,930,879              *Homo Sapiens*   Q6P1N0       Q6P1N0             --
  (Marker Locus: D19S840)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 18,207,961-18,255,419              *Homo Sapiens*   Q08493       Q08493             1LXU
  (Marker Locus: D19S212)                                                                                                                                                        

  Insulin receptor\                                                           Chromosome 19: 17,281,645-17,287,646              *Homo sapiens*   Q8NAG6       Q8NAG6             --
  (Marker locus: D19S410)                                                                                                                                                        

  Insulin receptor substrate 1                                                Chromosome 2: 226,731,317-226,799,759             *Homo Sapiens*   P35568       NP_005535          1IRS

  Peroxisome proliferator-activated receptor-gamma                            Chromosome 3: 12,287,368-12,434,356               *Homo Sapiens*   P37231       P37231             1FM6

  Mothers against decapentaplegic homolog 4(gene symbol: MADH4)               Chromosome 18: 51,028,394-51,085,045              *Homo sapiens*   Q13485       Q13485.1           1DD1

  Androgen receptor\                                                          Chromosome X: 67,544,032-67,730,619               *Homo Sapiens*   P10275       P10275             1E3G
  (Marker Locus: AR)                                                                                                                                                             

  CYP11A-cytochrome P450 side-chain cleavage enzyme\                          Chromosome 15: 74,337,759-74,367,740              *Homo Sapiens*   P05108       P05108             3N9Y
  Marker Locus: (D15S519)                                                                                                                                                        

  CYP17-cytochrome P450 17a-hydroxylasey17,20-desmolase\                      Chromosome 10: 102,830,531-102,837,533            *Homo Sapiens*   P05093       P05093             2C17
  Marker Locus: (D10S192)                                                                                                                                                        

  CYP19-cytochrome P450 aromatase\                                            Chromosome 15: 51,208,057-51,338,610              *Homo Sapiens*   P11511       P11511             1TQA
  Marker Locus: (CYP19)                                                                                                                                                          

  17 b-hydroxysteroid dehydrogenase, type I\                                  Chromosome 17: 42,549,214-42,555,213              *Homo Sapiens*   P14061       P14061             1A27
  Marker Locus: (D17S934)                                                                                                                                                        

  17 b-hydroxysteroid dehydrogenase, type II Marker Locus: (HSD17B2)          Chromosome 16: 82,035,004-82,098,534              *Homo Sapiens*   P37059       P37059             --

  17 b-hydroxysteroid dehydrogenase, type III Marker Locus: (D9S1809)         Chromosome 9: 96,235,306-96,302,152               *Homo Sapiens*   P37058       P37058             --

  3 b-hydroxysteroid dehydrogenase, type I and II Marker Locus: (D1S514)      Chromosome 1: 119,507,198-119,515,054             *Homo Sapiens*   P14060       P14060             --

  Steroidogenic acute regulatory protein Marker Locus: (D8S1821)              Chromosome 8: 38,143,649-38,151,265               *Homo Sapiens*   P49675       P49675             1IMG

  Activin receptor 1 Marker Locus: (D12S347)                                  Chromosome 10: 102,479,229-102,502,711            *Homo Sapiens*   P61163       P61163             --

  Activin receptor 2A\                                                        Chromosome 2: 147,844,517-147,930,826             *Homo Sapiens*   P27037       P27037             3Q4T
  Marker Locus: (D2S2335)                                                                                                                                                        

  Activin receptor 2B\                                                        Chromosome 3: 38,453,851-38,493,142               *Homo Sapiens*   Q13705       Q13705             2H6U
  Marker Locus:(D3S1298)                                                                                                                                                         

  Inhibin C Marker Locus: (D12S1691)                                          Chromosome 12, NC_000012.12 (57434685.57452062)   *Homo Sapiens*   P55103       P55103             --

  Follistatin Marker Locus: (D5S474)                                          Chromosome 5: 53,480,409-53,487,134               *Homo Sapiens*   P19883       P19883             --
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Modeled structures of proteins related to PCOS using Modeller 9v14 and Raptor X.

Table 2
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###### 

Microarray analysis results: significant genes found from Volcano Plot using *t*-test.

Table 3

  Significant genes annotation ID   Gene names                                         Gene     Chromosomal location   Regulation
  --------------------------------- -------------------------------------------------- -------- ---------------------- ------------
  200914_x\_at                      Kinectin 1 (kinesin receptor)                      KTN1     chr14q22.1             (+)
  211126_s\_at                      Cysteine and glycine-rich protein 2                CSRP2    chr12q21.1             (−)
  208852_s\_at                      Calnexin                                           CANX     chr5q35                (+)
  203951_at                         Calponin 1, basic, smooth muscle                   CNN1     chr19p13.2-p13.1       (+)
  210087_s\_at                      Myelin protein zero-like 1                         MPZL1    chr1q24.2              (+)
  212008_at                         UBX domain protein 4                               UBXN4    chr2q21.3              (+)
  217889_s\_at                      Cytochrome b reductase 1                           CYBRD1   chr2q31.1              (+)
  212713_at                         Microfibrillar-associated protein 4                MFAP4    chr17p11.2             (−)
  202216_x\_at                      Nuclear transcription factor Y, gamma              NFYC     chr1p32 \| 1p32        (+)
  215346_at                         CD40 molecule, TNF receptor superfamily member 5   CD40     chr20q12-q13.2         (+)
  219868_s\_at                      Ankyrin repeat and FYVE domain containing 1        ANKFY1   chr17p13.3             (−)
  214544_s\_at                      Synaptosomal-associated protein, 23kDa             SNAP23   chr15q14               (+)
  210756_s\_at                      Notch 2                                            NOTCH2   chr1p13-p11            (−)
  209196_at                         WD repeat domain 46                                WDR46    chr6p21.3              (−)
